The Role Of Cognitive Impairment In The Use Of The Diskus Inhaler

Completed

Conditions studied: Cognitive Impairment

In brief

The Diskus Inhaler is administered by a nurse or medical technician in the Nursing Home (NH) setting. The administration of the medication from the Diskus Inhaler includes 4 steps: open, click, inhale, close. The only step that the resident must do is the "inhale" step, which includes holding one's breath for 10 seconds after the inhalation. The investigators propose that properly trained and motivated nurses and medical technicians can successfully administer medication using the Advair Diskus to almost any mildly to moderately cognitively impaired resident who can follow the instruction- "inhale" and hold your breath for 10 seconds". The objective is to show that mild to moderate cognitive impairment should not be a barrier to the use of Diskus Inhaler. There will only be 1 consent visit and 1 evaluation visit per subject.

Key facts

Study ID

NCT00891059

Run by

Synergy Health Solutions

People needed

40

Starts

2009-05-01

Expected to finish

2009-07-01

Last updated by the study team

2010-11-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult men and women residing in a NH or ALF
• Mini Mental Status Exam (MMSE) score between 10 and 24 inclusive
• Able to hold breath for at least 10 seconds
• Able to speak and understand English

You may not qualify if…

• Current or history of Diskus use

Where it is running

• Brooksville Health Care Center — Brooksville, Florida, United States
• Bethany Village — Centerville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.